Drawing for MARQ3

USPTO serial 98792674

MARQ3

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
HOPKINS, SARAH COLLEEN
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with MARQ3?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*

Plus Government fees of $150

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joshua W. Newman

Joshua W. Newman Reed Smith LLP10 South Wacker Drive40th FloorChicago, IL 60606

Goods and services

ClassDescriptionStatusFirst use
005Gauze for dressings, vitamin and mineral supplements for veterinary purposes; animal health care products, namely, nutritional supplements; animal wound care products, namely, a healing gel being a hemostatic gel matrix preparation for treating wounds; post-operative and trauma management dressing for veterinary purposes, namely, wound dressings for post-operative and trauma management for animals; veterinary eye drops; bacteriological preparations for veterinary purposes; enema preparations for veterinary purposes; anti-diarrheal demulcent medicine for veterinary purposes; nutritional supplements for treating gastric disorders and to promote enteric health for veterinary purposes; antiseptic preparations for veterinary purposes; veterinary preparations for animal healthcare, namely, oral iodine, vitamin, and mineral supplements in bolus form for equine and bovine; veterinary pharmaceutical, namely, a pharmaceutical preparation for the treatment of incontinence in dogs; animal health care products, namely, protein supplements, vitamin supplements and mineral supplements; calcium phosphorus magnesium and potassium supplements for veterinary purposes; liquid hematinic nutritional supplemental preparations for animals; veterinary preparations for treating anxiety and central nervous system disorders in companion animals; oral animal feed supplements; dietary supplements veterinary purposes; oral re-hydration product for veterinary use, namely, oral rehydration salts; high calorie liquid diet for use as meal replacement, namely, meal replacement beverages adapted for veterinary use; none of the foregoing including or related to topical anesthetics, dental bite registration materials, materials for crowns and bridges for dental use, endodontic medicaments, hemostatic solution for dental use, dental impression materials, hemp seed oil in drops for use as a dietary supplement, hemp seed extract for medical and pharmaceutical use, hemp seed oil gummies for use as a dietary supplement, medicated hemp seed oil lip balm, nutritional supplements in the form of hemp seed oil gummies, fish oil for use as a dietary supplement, balms for medical purposes, balms for pharmaceutical purposes, analgesic balm, antibiotic creams, aromatherapy creams for treating headaches, relieving stress, curing insomnia, dietary and nutritional supplements containing hemp seed oil, fish oil, mushroom oil, dietary supplements in the form of capsules, liquid and powder, dietary supplements in the nature of weight loss powders, edible fish oils for medical purposes, gels, creams and solutions for dermatological use, medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets, vitamin drops, cod-liver oil dietary supplement drops, medical diagnostic test strips for urine analysis, intestinal support dietary and nutritional supplements, liquid zinc supplement drops, testosterone booster supplements, glucosamine, turmeric dietary supplements, curcumin dietary supplements, dietary supplements for liver detox, prebiotic, probiotic in the form of drops, capsules, tablets and compressed tablets, elderberry drops for use as a dietary supplement, iodine drops, or medicinal drops to promote lactationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 7, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 6, 2026EX1GSOU EXTENSION 1 GRANTED—
Aug 6, 2026EXT1SOU EXTENSION 1 FILED—
Aug 6, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 17, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 23, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 23, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 17, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 24, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 24, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Nov 24, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 24, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 24, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 24, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 24, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 24, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 9, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jul 9, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Apr 24, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 24, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 24, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 12, 2025DOCKASSIGNED TO EXAMINER—
Apr 10, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 9, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance